Early Initiation of Tocilizumab Treatment Against Moderate-to-Severe Myelitis in Neuromyelitis Optica Spectrum Disorder
Work
Year: 2021
Type: article
Abstract: Background Interleukin-6 receptor blockade is effective in reducing the risk of relapses in neuromyelitis optica spectrum disorder (NMOSD). However, its efficacy during acute attacks of NMOSD remains ... more
Source: Frontiers in Immunology
Institution Tianjin Medical University General Hospital
Cites: 32
Cited by: 16
Related to: 10
FWCI: 2.356
Citation percentile (by year/subfield): 85.15
Subfield: Pathology and Forensic Medicine
Field: Medicine
Domain: Health Sciences
Sustainable Development Goal Good health and well-being
Open Access status: gold
APC paid (est): $2,950